澳门太阳游戏城app官网入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.

Gastroenterology. 2018-01; 
PhamLong V,RamirezSantseharay,GottweinJudith M,FahnøeUlrik,LiYi-Ping,PedersenJannie,Bukh
Products/Services Used Details Operation
Gene Synthesis … The 3ʹUTR, including sequences of HK6a (Supplementary Results) and of H77 (the 3ʹ terminal stem-loop), 20 was synthesized by GenScript. These sequences were assembled into pHK6a 5ʹUTR-NS2 /JFH1 8 using standard cloning procedures … Get A Quote

摘要

Chronic liver diseases caused by hepatitis C virus (HCV) genotype 6 are prevalent in Asia, and millions of people require treatment with direct-acting antiviral regimens, such as NS5A inhibitor velpatasvir combined with the NS5B polymerase inhibitor sofosbuvir. We developed infectious cell culture models of HCV genotype 6a infection to study the effects of these inhibitors and the development of resistance.

关键词

DAA,Escape Variants,In Vitro System,Nucleotide An